A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.
about
Algorithms for the diagnosis and treatment of restless legs syndrome in primary careLong-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled studyStrategies for the treatment of restless legs syndromeThe treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice GuidelGabapentin enacarbil - clinical efficacy in restless legs syndromeReview: management of Parkinson's disease.The use of gabapentin enacarbil in the treatment of restless legs syndrome.Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.Role of gabapentin enacarbil XR in restless legs syndromeReview of the treatment of restless legs syndrome: focus on gabapentin enacarbil.Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose?Gabapentin enacarbil: pharmacotherapy of restless legs syndromeEfficacy and Tolerability of Gabapentin in Adults with Sleep Disturbance in Medical Illness: A Systematic Review and Meta-analysis.SLEEP AND CIRCADIAN RHYTHM DISORDERS IN PARKINSON'S DISEASE.
P2860
Q21261396-64EEBC42-770B-4AA2-A898-BA81F422F017Q24603670-9A6507C2-B2E2-4C3C-9C9D-CE12C06F56BBQ26829911-C1B3FA68-FDA8-48B5-A4FE-ED25D97F6DBBQ27024854-6A508CD8-8E81-419D-8C8A-7374906360A9Q33868110-69697178-FADC-4674-9591-303D1AD16C9EQ34332812-CAA3D373-B164-412A-87B2-501DD4A977F3Q34409544-1D1C5869-CCF1-4590-ABD5-6DC0A1D7CDBDQ34544928-3753E3B5-5B5A-4A27-A4A6-CB0639C58228Q35042278-03AD3892-337C-4413-87BF-3813262BECCDQ35940214-0E39F43D-870A-41CD-A7C2-475C6DD93AF8Q36748697-BBAEB8C2-3719-4D95-81B8-BAAC47BAC1BCQ37577779-5269B0C9-E4F3-4628-B642-69CA0DD24F53Q38122149-903D168E-98F7-4EEF-9B56-18D80FBE705CQ41015870-FBFFC669-9C12-47FF-9C7E-954B77A43863Q47659714-EB3190B4-3B52-41BF-82C1-D3EFFF56F16A
P2860
A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A randomized, double-blind, pl ...... rimary restless legs syndrome.
@en
A randomized, double-blind, pl ...... rimary restless legs syndrome.
@nl
type
label
A randomized, double-blind, pl ...... rimary restless legs syndrome.
@en
A randomized, double-blind, pl ...... rimary restless legs syndrome.
@nl
prefLabel
A randomized, double-blind, pl ...... rimary restless legs syndrome.
@en
A randomized, double-blind, pl ...... rimary restless legs syndrome.
@nl
P2093
P2860
P1433
P1476
A randomized, double-blind, pl ...... rimary restless legs syndrome.
@en
P2093
A Thomas Perkins
Arthur S Walters
Clete A Kushida
Daniel Canafax
Philip Becker
Ronald W Barrett
Stephen G Thein
Thomas Roth
XP021 Study Group
P2860
P304
P577
2009-02-01T00:00:00Z